LKQ Corp. Stock Slides 22.5%, Underperforms Peers
Dow Jones2026/10/23 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of LKQ Corp. plummeted 22.5% to $17.42 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,623.68 and Dow Jones Industrial Average falling 1.2% to 52,215.16.
LKQ Corp. closed 53.1% short of its 52-week high of $37.13, which the company reached on January 26th.
The stock underperformed when compared to some of its peers, as Genuine Parts Co. fell 3.9% to $123.02, QuantumScape Corp. Cl A fell 2.9% to $4.03, and BorgWarner Inc. fell 0.90% to $54.96.
Trading volume totaled 23.1 million, compared to the 50-day average of 3.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 23, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Profit surges 7-fold, revenue breaks 100 trillions for the first time: SK hynix (SKHY.US) responds to AI bubble concerns with record-breaking quarterly report
SK Hynix reported an operating profit of 83.3 trillion won for the third quarter, surpassing expectations, and announced shareholder returns of approximately 100 trillion won within the year.
AstraZeneca (AZN.US) CEO hints at entry into cancer vaccines: years of experience with mRNA technology and more updates expected in the coming months
AstraZeneca is considering developing a cancer vaccine, with the CEO stating that the company has already accumulated experience in mRNA technology. Personalized vaccines have reduced the recurrence rate of melanoma by 42%, but cost and production capacity remain obstacles to broader adoption.
Crypto prices
More
